Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-15

Clinical Trial Update: Impact of Carrier Solutions for House Dust Mite Allergen on Allergic Reactions [NA]

View source ↗

Summary

A completed clinical trial evaluated carrier solutions for house dust mite allergen and their effect on allergic reactions in allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fraunhofer-Institute of Toxicology and Experimental Medicine | Conditions: Allergic Rhinitis | NA | Status: COMPLETED